{
    "clinical_study": {
        "@rank": "75434", 
        "arm_group": [
            {
                "arm_group_label": "BiPAP - A40", 
                "arm_group_type": "Experimental", 
                "description": "BiPAP with AVAPS AE mode"
            }, 
            {
                "arm_group_label": "BiPAP- ST", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients receiving BiPAP- ST at home"
            }
        ], 
        "brief_summary": {
            "textblock": "In 2012, it has announced the availability of the new ventilator (BiPAP- A40), which could\n      offer potential advantages over fixed level pressure support, in particular, in patients\n      with obesity hypoventilation syndrome (OHS). One of the key benefits of the BiPAP A40 is an\n      innovative ventilation mode called AVAPS-AE, which automatically maintains airway patency\n      while delivering the correct level of ventilation each user requires, whatever their body\n      position or sleep stage. AVAPS-AE mode is also aimed to help the clinicians during the\n      initial titration of therapy, while providing long term comfort and assuring therapy\n      compliance. However, studies on the physiologic and clinical effects have not yet been\n      performed. The aim of our singled-blind randomised multicentre controlled trial is to\n      prospectively investigate the effects of  BiPAP with the spontaneous/timed (S/T) or the\n      AVAPS-AE ventilation mode over 8 weeks on sleep quality, ventilation pattern, gas exchange,\n      symptoms, body composition, level of physical activity and health-related quality of life in\n      OHS patients."
        }, 
        "brief_title": "Non Invasive Ventilation : Efficacy of a New Ventilatory Mode in Patients With OHS", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Obesity Hypoventilation Syndrome", 
        "condition_browse": {
            "mesh_term": [
                "Obesity", 
                "Obesity Hypoventilation Syndrome", 
                "Hypoventilation", 
                "Respiratory Insufficiency"
            ]
        }, 
        "detailed_description": {
            "textblock": "Efficacy on sleep quality, symptoms, physical activity and quality of life"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Man or woman, stable patient with obesity hypoventilation syndrome, naives of non\n             invasive ventilation.\n\n          -  PaCO2 \u2265 45 mmHg.\n\n          -  PaO2 < 70 mmHg\n\n          -  BMI \u2265 30Kg. m2\n\n        Exclusion Criteria:\n\n          -  Chronic obstructive pulmonary disease\n\n          -  Neuromuscular disease\n\n          -  Scoliosis\n\n          -  Cardiac insufficiency\n\n          -  Significant psychiatric disease\n\n          -  Sleep apnea syndrome with central apnea index > 10%\n\n          -  Treatment with benzodiazepines at the inclusion"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 17, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01757444", 
            "org_study_id": "2012 - A00731 - 42", 
            "secondary_id": "EVAL CLIN - VENTILATEUR"
        }, 
        "intervention": [
            {
                "arm_group_label": "BiPAP - A40", 
                "description": "Patients receiving BiPAP AVAPS - AE ventilatory mode at home", 
                "intervention_name": "BiPAP - A40", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "BiPAP- ST", 
                "description": "Patients receiving BiPAP- ST mode at home.", 
                "intervention_name": "BiPAP - ST", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 4, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Beziers", 
                        "country": "France"
                    }, 
                    "name": "Centre Hospitalier de B\u00e9ziers"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bordeaux", 
                        "country": "France"
                    }, 
                    "name": "H\u00f4pital Haut- L\u00e9v\u00eaque"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cannes", 
                        "country": "France"
                    }, 
                    "name": "Centre Hospitalier de Cannes"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dijon", 
                        "country": "France"
                    }, 
                    "name": "H\u00f4pital du Bocage"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Grenoble", 
                        "country": "France"
                    }, 
                    "name": "H\u00f4pital Michallon"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France"
                    }, 
                    "name": "H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Poitiers", 
                        "country": "France"
                    }, 
                    "name": "H\u00f4pital La Mil\u00e9trie"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "email": "Jean-Francois.Muir@chu-rouen.fr", 
                    "last_name": "Jean Fran\u00e7ois MUIR, Pr"
                }, 
                "facility": {
                    "address": {
                        "city": "Rouen", 
                        "country": "France"
                    }, 
                    "name": "H\u00f4pital de Bois Guillaume"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toulouse", 
                        "country": "France"
                    }, 
                    "name": "H\u00f4pital Larrey"
                }, 
                "status": "Active, not recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Clinical Benefits and Tolerance to a New Ventilatory Mode in Patients With Obesity Hypoventilation Syndrome (OHS).", 
        "other_outcome": {
            "measure": "CHANGE IN QUALITY OF LIFE/ LEVEL OF PHYSICAL ACTIVITY/ BODY COMPOSITION", 
            "safety_issue": "Yes", 
            "time_frame": "Day 1 and Day 61"
        }, 
        "overall_contact": {
            "email": "annabelle.couillard@yahoo.fr", 
            "last_name": "Annabelle COUILLARD, Ph.D"
        }, 
        "overall_official": {
            "affiliation": "Association Nationale pour le Traitement \u00e0 Domicile de l'Insuffisance Respiratoire", 
            "last_name": "Jean-Fran\u00e7ois MUIR, Pr", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Sleep stage, micro arousals, apnea/hypopnea index...", 
            "measure": "CHANGE IN SLEEP QUALITY", 
            "safety_issue": "Yes", 
            "time_frame": "Day 1 and Day 61"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01757444"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Association Nationale pour le Traitement \u00e0 Domicile de l'Insuffisance Respiratoire", 
            "investigator_full_name": "COUILLARD Annabelle", 
            "investigator_title": "Coordinator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "CHANGE IN GAZ EXCHANGE", 
            "safety_issue": "Yes", 
            "time_frame": "Day 1 and Day 61"
        }, 
        "source": "Association Nationale pour le Traitement \u00e0 Domicile de l'Insuffisance Respiratoire", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Association Nationale pour le Traitement \u00e0 Domicile de l'Insuffisance Respiratoire", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}